Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: a cross-sectional study

Kamila Kamili,Tingting Zheng,Chaodi Luo,Xuan Wang,Gang Tian
DOI: https://doi.org/10.1186/s12944-023-01990-1
2024-01-24
Lipids in Health and Disease
Abstract:Current guidelines are debated when it comes to starting anticoagulant therapy in patients with non-valvular atrial fibrillation (NVAF) and low CHA 2 DS 2 -VASc scores (1–2 in women and 0–1 in men). However, these individuals still have a high likelihood of developing left atrial thrombus/spontaneous echo contrast (LAT/SEC) and experiencing subsequent thromboembolism. Recent research has demonstrated that lipoprotein(a) [Lp(a)] may increase the risk of thrombosis, but the relationship between Lp(a) and LAT/SEC in NVAF patients is not clearly established. Therefore, this study sought to evaluate the predictive ability of Lp(a) for LAT/SEC among NVAF patients with low CHA 2 DS 2 -VASc scores.
biochemistry & molecular biology,nutrition & dietetics
What problem does this paper attempt to address?